Published in Diabetes on January 01, 2001
Initiation and execution of lipotoxic ER stress in pancreatic beta-cells. J Cell Sci (2008) 2.99
Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale. Physiol Rev (2010) 2.68
Structural basis for the selective inhibition of JNK1 by the scaffolding protein JIP1 and SP600125. EMBO J (2004) 2.53
Identification of a new JNK inhibitor targeting the JNK-JIP interaction site. Proc Natl Acad Sci U S A (2008) 2.26
Prevention of steatosis by hepatic JNK1. Cell Metab (2009) 2.20
Role for activating transcription factor 3 in stress-induced beta-cell apoptosis. Mol Cell Biol (2004) 2.10
Targeting innate immunity protein kinase signalling in inflammation. Nat Rev Drug Discov (2009) 2.01
JNK3 perpetuates metabolic stress induced by Aβ peptides. Neuron (2012) 1.80
A genome-wide RNA interference screen reveals an essential CREB3L2-ATF5-MCL1 survival pathway in malignant glioma with therapeutic implications. Nat Med (2010) 1.55
The regulation of ATF3 gene expression by mitogen-activated protein kinases. Biochem J (2007) 1.52
Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis. Mediators Inflamm (2010) 1.49
Cytokine-induced beta-cell death is independent of endoplasmic reticulum stress signaling. Diabetes (2008) 1.46
Prostate cancer induces bone metastasis through Wnt-induced bone morphogenetic protein-dependent and independent mechanisms. Cancer Res (2008) 1.34
Mechanisms of aminoglycoside ototoxicity and targets of hair cell protection. Int J Otolaryngol (2011) 1.32
Mcl-1 downregulation by pro-inflammatory cytokines and palmitate is an early event contributing to β-cell apoptosis. Cell Death Differ (2010) 1.30
Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes. Curr Diabetes Rev (2013) 1.21
JNK MAP kinase activation is required for MTOC and granule polarization in NKG2D-mediated NK cell cytotoxicity. Proc Natl Acad Sci U S A (2008) 1.17
Glucocorticoid receptor-JNK interaction mediates inhibition of the JNK pathway by glucocorticoids. EMBO J (2003) 1.11
JNK signaling in neomycin-induced vestibular hair cell death. Hear Res (2006) 1.10
Development of paramagnetic probes for molecular recognition studies in protein kinases. J Med Chem (2008) 1.09
Negative regulation of ASK1 by p21Cip1 involves a small domain that includes Serine 98 that is phosphorylated by ASK1 in vivo. Mol Cell Biol (2007) 1.09
Phosphorylation-dependent interaction with 14-3-3 in the regulation of bad trafficking in retinal ganglion cells. Invest Ophthalmol Vis Sci (2008) 1.07
Intracellular peptides as natural regulators of cell signaling. J Biol Chem (2008) 1.07
Targeting tyrosine phosphorylation of PCNA inhibits prostate cancer growth. Mol Cancer Ther (2011) 1.02
Inhibition of JNK by a peptide inhibitor reduces traumatic brain injury-induced tauopathy in transgenic mice. J Neuropathol Exp Neurol (2012) 1.02
The Stimulation of CD147 Induces MMP-9 Expression through ERK and NF-kappaB in Macrophages: Implication for Atherosclerosis. Immune Netw (2009) 1.01
Novel strategy for treatment of viral central nervous system infection by using a cell-permeating inhibitor of c-Jun N-terminal kinase. J Virol (2007) 1.01
Serpin squamous cell carcinoma antigen inhibits UV-induced apoptosis via suppression of c-JUN NH2-terminal kinase. J Cell Biol (2006) 1.01
Involvement of oxidative stress and the JNK pathway in glucose toxicity. Rev Diabet Stud (2005) 1.01
Contribution of the sympathetic hormone epinephrine to the sensitizing effect of ethanol on LPS-induced liver damage in mice. Am J Physiol Gastrointest Liver Physiol (2008) 1.01
cJUN N-terminal kinase (JNK) activation mediates islet amyloid-induced beta cell apoptosis in cultured human islet amyloid polypeptide transgenic mouse islets. Diabetologia (2011) 0.99
Design, synthesis, and structure-activity relationship of substrate competitive, selective, and in vivo active triazole and thiadiazole inhibitors of the c-Jun N-terminal kinase. J Med Chem (2009) 0.98
Understanding the specificity of a docking interaction between JNK1 and the scaffolding protein JIP1. J Phys Chem B (2011) 0.97
Tumor necrosis factor alpha stimulates NMDA receptor activity in mouse cortical neurons resulting in ERK-dependent death. J Neurochem (2007) 0.96
Crosstalk between JNK and SUMO signaling pathways: deSUMOylation is protective against H2O2-induced cell injury. PLoS One (2011) 0.96
c-Jun N-terminal kinase regulates soluble Aβ oligomers and cognitive impairment in AD mouse model. J Biol Chem (2011) 0.96
Varicella-zoster virus infection of human fibroblast cells activates the c-Jun N-terminal kinase pathway. J Virol (2006) 0.96
A unique set of SH3-SH3 interactions controls IB1 homodimerization. EMBO J (2006) 0.95
Regulation of CCAAT/enhancer-binding protein homologous protein (CHOP) expression by interleukin-1 beta in pancreatic beta cells. J Biol Chem (2010) 0.94
Zinc transporter gene expression is regulated by pro-inflammatory cytokines: a potential role for zinc transporters in beta-cell apoptosis? BMC Endocr Disord (2009) 0.94
Development of JNK2-selective peptide inhibitors that inhibit breast cancer cell migration. ACS Chem Biol (2011) 0.94
Identification of a novel transport-independent function of PiT1/SLC20A1 in the regulation of TNF-induced apoptosis. J Biol Chem (2010) 0.93
Docking interactions of the JNK scaffold protein WDR62. Biochem J (2011) 0.92
Increased sensitivity to apoptosis induced by methotrexate is mediated by JNK. Arthritis Rheum (2011) 0.92
Huntingtin-interacting protein 14 is a type 1 diabetes candidate protein regulating insulin secretion and beta-cell apoptosis. Proc Natl Acad Sci U S A (2011) 0.91
c-Jun NH2-terminal kinase mediates interleukin-1beta-induced inhibition of lacrimal gland secretion. J Neurochem (2005) 0.91
Modulation of apoptosis pathways by oxidative stress and autophagy in β cells. Exp Diabetes Res (2012) 0.90
Therapeutic effect of c-Jun N-terminal kinase inhibition on pancreatic cancer. Cancer Sci (2013) 0.90
Retracted Neutralizing interleukin-1beta (IL-1beta) induces beta-cell survival by maintaining PDX1 protein nuclear localization. J Biol Chem (2011) 0.88
The proteasome is an integral part of solar ultraviolet a radiation-induced gene expression. J Biol Chem (2009) 0.87
MAPK kinase kinase-1 is essential for cytokine-induced c-Jun NH2-terminal kinase and nuclear factor-kappaB activation in human pancreatic islet cells. Diabetes (2008) 0.87
Neuroprotective role of PrPC against kainate-induced epileptic seizures and cell death depends on the modulation of JNK3 activation by GluR6/7-PSD-95 binding. Mol Biol Cell (2011) 0.86
Differential activation of JNK1 isoforms by TRAIL receptors modulate apoptosis of colon cancer cell lines. Br J Cancer (2009) 0.86
Immune receptor expressed on myeloid cells 1 (IREM-1) inhibits B cell activation factor (BAFF)-mediated inflammatory regulation of THP-1 cells through modulation of the activities of extracellular regulated kinase (ERK). Clin Exp Immunol (2010) 0.86
Enhancing and limiting endothelin-1 signaling with a cell-penetrating peptide mimicking the third intracellular loop of the ETB receptor. Chem Biol Drug Des (2012) 0.85
GPCR-like signaling mediated by smoothened contributes to acquired chemoresistance through activating Gli. Mol Cancer (2014) 0.85
Discovery of 2-(5-nitrothiazol-2-ylthio)benzo[d]thiazoles as novel c-Jun N-terminal kinase inhibitors. Bioorg Med Chem (2009) 0.85
Selective repression of low-density lipoprotein receptor expression by SP600125: coupling of histone H3-Ser10 phosphorylation and Sp1 occupancy. Mol Cell Biol (2006) 0.85
Synthesis and optimization of thiadiazole derivatives as a novel class of substrate competitive c-Jun N-terminal kinase inhibitors. Bioorg Med Chem (2009) 0.84
BAFF and APRIL induce inflammatory activation of THP-1 cells through interaction with their conventional receptors and activation of MAPK and NF-κB. Inflamm Res (2011) 0.84
Stimulation of FasL induces production of proinflammatory mediators through activation of mitogen-activated protein kinases and nuclear factor-κB in THP-1 cells. Inflammation (2012) 0.84
JNK3 maintains expression of the insulin receptor substrate 2 (IRS2) in insulin-secreting cells: functional consequences for insulin signaling. PLoS One (2012) 0.84
Clathrin-mediated post-Golgi membrane trafficking in the morphogenesis of hepatitis delta virus. J Virol (2009) 0.84
In vivo JNK activation in pancreatic β-cells leads to glucose intolerance caused by insulin resistance in pancreas. Diabetes (2013) 0.83
Regulation of leukemic cell differentiation and retinoid-induced gene expression by statins. Mol Cancer Ther (2009) 0.83
Bad news for beta-cell apoptosis. Diabetes (2009) 0.83
A major effect of simulated microgravity on several stages of preimplantation mouse development is lethality associated with elevated phosphorylated SAPK/JNK. Reprod Sci (2009) 0.83
Copy-number variation of the neuronal glucose transporter gene SLC2A3 and age of onset in Huntington's disease. Hum Mol Genet (2014) 0.83
Neuroprotection by inhibiting the c-Jun N-terminal kinase pathway after cerebral ischemia occurs independently of interleukin-6 and keratinocyte-derived chemokine (KC/CXCL1) secretion. J Neuroinflammation (2012) 0.83
Role of TAB1 in nitric oxide-induced p38 activation in insulin-producing cells. Int J Biol Sci (2006) 0.83
TNFα signals via p66(Shc) to induce E-Selectin, promote leukocyte transmigration and enhance permeability in human endothelial cells. PLoS One (2013) 0.83
The impact of JNK inhibitor D-JNKI-1 in a murine model of chronic colitis induced by dextran sulfate sodium. J Inflamm Res (2013) 0.83
Quantitative proteomics reveals dynamic interaction of c-Jun N-terminal kinase (JNK) with RNA transport granule proteins splicing factor proline- and glutamine-rich (Sfpq) and non-POU domain-containing octamer-binding protein (Nono) during neuronal differentiation. Mol Cell Proteomics (2014) 0.82
A combined "omics" approach identifies N-Myc interactor as a novel cytokine-induced regulator of IRE1 protein and c-Jun N-terminal kinase in pancreatic beta cells. J Biol Chem (2014) 0.82
Parkinson's disease-associated mutations in DJ-1 modulate its dimerization in living cells. J Mol Med (Berl) (2012) 0.82
JNK Signaling: Regulation and Functions Based on Complex Protein-Protein Partnerships. Microbiol Mol Biol Rev (2016) 0.81
Presynaptic c-Jun N-terminal Kinase 2 regulates NMDA receptor-dependent glutamate release. Sci Rep (2015) 0.81
Differential Relevance of NF-κB and JNK in the Pathophysiology of Hemorrhage/Resususcitation-Induced Liver Injury after Chronic Ethanol Feeding. PLoS One (2015) 0.81
Design and characterization of a potent and selective dual ATP- and substrate-competitive subnanomolar bidentate c-Jun N-terminal kinase (JNK) inhibitor. J Med Chem (2011) 0.81
Activation of CD147 with cyclophilin a induces the expression of IFITM1 through ERK and PI3K in THP-1 cells. Mediators Inflamm (2010) 0.81
ER stress and the decline and fall of pancreatic beta cells in type 1 diabetes. Ups J Med Sci (2016) 0.81
Targeted inhibition of metastatic melanoma through interference with Pin1-FOXM1 signaling. Oncogene (2015) 0.81
Endogenous protease nexin-1 protects against cerebral ischemia. Int J Mol Sci (2013) 0.80
JNK at the crossroad of obesity, insulin resistance, and cell stress response. Mol Metab (2016) 0.80
Jnk1 Deficiency in Hematopoietic Cells Suppresses Macrophage Apoptosis and Increases Atherosclerosis in Low-Density Lipoprotein Receptor Null Mice. Arterioscler Thromb Vasc Biol (2016) 0.80
Development of an intracellularly acting inhibitory peptide selective for PKN. Biochem J (2009) 0.80
Activation of JNK triggers release of Brd4 from mitotic chromosomes and mediates protection from drug-induced mitotic stress. PLoS One (2012) 0.80
Combination Therapies for Traumatic Brain Injury: Retrospective Considerations. J Neurotrauma (2015) 0.80
c-Myc potentiates the mitochondrial pathway of apoptosis by acting upstream of apoptosis signal-regulating kinase 1 (Ask1) in the p38 signalling cascade. Biochem J (2003) 0.80
Regulation of adipocyte differentiation by distinct subcellular pools of protein kinase B (PKB/Akt). J Biol Chem (2010) 0.80
Small-molecule inhibition of inflammatory β-cell death. Diabetes Obes Metab (2013) 0.80
c-Jun N-terminal kinase has a key role in Alzheimer disease synaptic dysfunction in vivo. Cell Death Dis (2014) 0.80
Manufacturing porcine islets: culture at 22 °C has no advantage above culture at 37 °C: a gene expression evaluation. Xenotransplantation (2013) 0.78
Design, synthesis, and structure-activity relationship studies of thiophene-3-carboxamide derivatives as dual inhibitors of the c-Jun N-terminal kinase. Bioorg Med Chem (2011) 0.78
Non-apoptotic toxicity of Pseudomonas aeruginosa toward murine cells. PLoS One (2013) 0.78
Retroinverso analogs of spadin display increased antidepressant effects. Psychopharmacology (Berl) (2014) 0.78
Methotrexate-mediated inhibition of nuclear factor κB activation by distinct pathways in T cells and fibroblast-like synoviocytes. Rheumatology (Oxford) (2014) 0.78
Excitotoxicity through Ca2+-permeable AMPA receptors requires Ca2+-dependent JNK activation. Neurobiol Dis (2010) 0.77
Structural basis and biological consequences for JNK2/3 isoform selective aminopyrazoles. Sci Rep (2015) 0.77
Pro-life role for c-Jun N-terminal kinase and p38 mitogen-activated protein kinase at rostral ventrolateral medulla in experimental brain stem death. J Biomed Sci (2012) 0.77
Kerato-epithelin mutations in four 5q31-linked corneal dystrophies. Nat Genet (1997) 4.43
Mutations of keratinocyte transglutaminase in lamellar ichthyosis. Science (1995) 3.44
A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy. Nat Genet (1999) 3.32
Missense mutations in COL8A2, the gene encoding the alpha2 chain of type VIII collagen, cause two forms of corneal endothelial dystrophy. Hum Mol Genet (2001) 3.06
The gamma-crystallins and human cataracts: a puzzle made clearer. Am J Hum Genet (1999) 2.81
Genetic heterogeneity of the Coppock-like cataract: a mutation in CRYBB2 on chromosome 22q11.2. Invest Ophthalmol Vis Sci (2000) 1.86
Allelic variation in the VMD2 gene in best disease and age-related macular degeneration. Invest Ophthalmol Vis Sci (2000) 1.84
The gene mutated in thiamine-responsive anaemia with diabetes and deafness (TRMA) encodes a functional thiamine transporter. Nat Genet (1999) 1.69
Variation of codons 1961 and 2177 of the Stargardt disease gene is not associated with age-related macular degeneration. Arch Ophthalmol (2001) 1.68
Study of a Swiss dopa-responsive dystonia family with a deletion in GCH1: redefining DYT14 as DYT5. Neurology (2007) 1.62
Mutation hot spots in 5q31-linked corneal dystrophies. Am J Hum Genet (1998) 1.42
A progressive autosomal recessive cataract locus maps to chromosome 9q13-q22. Am J Hum Genet (2001) 1.41
Amyloid and non-amyloid forms of 5q31-linked corneal dystrophy resulting from kerato-epithelin mutations at Arg-124 are associated with abnormal turnover of the protein. J Biol Chem (2000) 1.34
Circadian regulation of islet genes involved in insulin production and secretion. Mol Cell Endocrinol (2004) 1.16
Genetic linkage of Bietti crystallin corneoretinal dystrophy to chromosome 4q35. Am J Hum Genet (2000) 1.14
Study of the excitability cycle of the blink reflex in Huntington's chorea. Eur Neurol (1976) 1.13
On the role of kerato-epithelin in the pathogenesis of 5q31-linked corneal dystrophies. Invest Ophthalmol Vis Sci (1999) 1.13
Linkage of the steroid sulfatase gene to the sex-reversed mutation in the mouse. Genetics (1987) 1.10
High rate of recombination and double crossovers in the mouse pseudoautosomal region during male meiosis. Proc Natl Acad Sci U S A (1987) 1.09
IB1 reduces cytokine-induced apoptosis of insulin-secreting cells. J Biol Chem (2000) 1.09
Cloning and characterization of Helicobacter pylori succinyl CoA:acetoacetate CoA-transferase, a novel prokaryotic member of the CoA-transferase family. J Biol Chem (1997) 1.08
The human pseudoautosomal GM-CSF receptor alpha subunit gene is autosomal in mouse. Nat Genet (1992) 1.08
Activity analysis of housekeeping promoters using self-inactivating lentiviral vector delivery into the mouse retina. Gene Ther (2003) 1.07
Regulation of photosynthesis in nitrogen deficient wheat seedlings. Plant Physiol (1988) 1.07
Delineation of a 1-cM region on distal 5q containing the locus for corneal dystrophies Groenouw type I and lattice type I and exclusion of the candidate genes SPARC and LOX. Eur J Hum Genet (1996) 1.02
Study of the dispersion of motor nerve conduction velocity in charcot-marie-tooth-hoffmann disease and in steinert's syndrome. Z Neurol (1972) 1.02
Lentiviral vector-mediated gene transfer in adult mouse photoreceptors is impaired by the presence of a physical barrier. Gene Ther (2005) 1.02
Gene localization for aculeiform cataract, on chromosome 2q33-35. Am J Hum Genet (1998) 1.02
Keratoepithelin in secondary corneal amyloidosis. Graefes Arch Clin Exp Ophthalmol (2005) 1.00
cDNA cloning and mapping of a novel islet-brain/JNK-interacting protein. Genomics (2000) 1.00
Full characterization of the maculopathy associated with an Arg-172-Trp mutation in the RDS/peripherin gene. Ophthalmic Genet (1996) 0.98
Mutation in the gene for connexin 30.3 in a family with erythrokeratodermia variabilis. Am J Hum Genet (2000) 0.97
New VMD2 gene mutations identified in patients affected by Best vitelliform macular dystrophy. J Med Genet (2007) 0.95
Ultrastructural and molecular analysis of Bowman's layer corneal dystrophies: an epithelial origin? Invest Ophthalmol Vis Sci (2000) 0.95
Male infant with ichthyosis, Kallmann syndrome, chondrodysplasia punctata, and an Xp chromosome deletion. Am J Med Genet (1989) 0.94
Identification of novel VMD2 gene mutations in patients with best vitelliform macular dystrophy. Hum Mutat (2001) 0.93
Characterization of the promoter region of the mouse Xist gene. Proc Natl Acad Sci U S A (1995) 0.92
Myotonic dystrophy with neural involvement. J Neurol Sci (1972) 0.92
Familial subepithelial corneal amyloidosis (gelatinous drop-like corneal dystrophy): exclusion of linkage to lactoferrin gene. Mol Vis (1998) 0.90
Changes in morphology and infectivity of cell culture-derived trypomastigotes of Trypanosoma cruzi. Mol Biochem Parasitol (1982) 0.89
Evidence of somatic and germinal mosaicism in pseudo-low-penetrant hereditary retinoblastoma, by constitutional and single-sperm mutation analysis. Am J Hum Genet (1998) 0.89
Retinal dystrophy in the oculo-auricular syndrome due to HMX1 mutation. Ophthalmic Genet (2011) 0.88
Trypanosoma cruzi: polypeptide markers of epimastigotes and trypomastigotes. Mol Biochem Parasitol (1986) 0.88
Rearrangements of minisatellites in the human telomerase reverse transcriptase gene are not correlated with its expression in colon carcinomas. Oncogene (2001) 0.88
Genomic organization, fine-mapping, and expression of the human islet-brain 1 (IB1)/c-Jun-amino-terminal kinase interacting protein-1 (JIP-1) gene. Genomics (1999) 0.86
Genotype-phenotype correlation of age-related macular degeneration: influence of complement factor H polymorphism. Br J Ophthalmol (2008) 0.85
Comparison of female geriatric lumbar-extension strength: asymptotic versus chronic low back pain patients and their response to active rehabilitation. J Spinal Disord (1996) 0.85
"C" trigonocephaly syndrome with diaphragmnatic hernia. Genet Couns (1995) 0.85
Neurological and pharmacological evaluation of a case of stiff-man syndrome. J Neurol (1980) 0.85
[Optical coherence tomography in Malattia Leventinese]. Klin Monbl Augenheilkd (2005) 0.85
Defective catabolism of oxidized LDL by J774 murine macrophages. J Lipid Res (1992) 0.83
Friedreich's ataxia. I. Clinical, neurophysiological and in vivo biochemical studies. Ital J Neurol Sci (1980) 0.83
[The significance of enviromental and biological monitoring in workers employed in service stations after the elimitation of tetraethyl lead from gasoline]. G Ital Med Lav Ergon (2005) 0.83
The tubulin genes of Trypanosoma cruzi. Eur J Biochem (1988) 0.83
Morphological, clinical and genetic aspects in a family with a novel LAMP-2 gene mutation (Danon disease). Neuromuscul Disord (2005) 0.82
Clinical and immunopathological corneal phenotype in homozygotes for the BIGH3 R124H mutation. Eye (Lond) (2005) 0.81
Systemic carnitine deficiency with peripheral nerve involvement morphological and biochemical study. Acta Neuropathol Suppl (1981) 0.81
Young children with Velo-Cardio-Facial syndrome (CATCH-22). Psychological and language phenotypes. Eur Child Adolesc Psychiatry (2000) 0.81
Familial trigeminal neuralgia in Charcot-Marie-Tooth disease. J Neurol (1981) 0.81
Identification of novel PAX6 mutations in two families with bilateral aniridia. Mutations in brief no. 167. Online. Hum Mutat (1998) 0.81
Treatment options in patients with recurrent ovarian cancer. Anticancer Res (2002) 0.80
Prenatal diagnosis and investigation of a fetus with chondrodysplasia punctata, ichthyosis, and Kallmann syndrome due to an Xp deletion. Prenat Diagn (1992) 0.80
[Mutational screening of peripherin/RDS genes, rhodopsin and ROM-1 in 69 index cases with retinitis pigmentosa and other retinal dystrophies]. Klin Monbl Augenheilkd (1998) 0.80
Haplotye analysis of Jaanese families with a superficial variant of granular corneal dystrohy: evidence for multiple origins of R124L mutation of keratoepithelin. Ophthalmic Genet (2000) 0.80
Patient with Fanconi Syndrome (FS) and retinitis pigmentosa (RP) caused by a deletion and duplication of mitochondrial DNA (mtDNA). Klin Monbl Augenheilkd (2007) 0.79
A test to measure lift capacity of physically impaired adults. Part 2--Reactivity in a patient sample. Spine (Phila Pa 1976) (1995) 0.79
A case of scapulo-tibio-peroneal syndrome. Electromyographic and histoenzymologic considerations. Eur Neurol (1973) 0.79
Fatal outcome in a female monozygotic twin with X-linked hypohydrotic ectodermal dysplasia (XLHED) due to a de novo t(X;9) translocation with probable disruption of the EDA gene. Eur J Pediatr (2001) 0.79
Methylation status of CpG sites and methyl-CpG binding proteins are involved in the promoter regulation of the mouse Xist gene. Gene Expr (1998) 0.79
Rhodopsin C110Y mutation causes a type 2 autosomal dominant retinitis pigmentosa. Ophthalmic Genet (1998) 0.79
De novo mutation in the BIGH3/TGFB1 gene causing granular corneal dystrophy. Br J Ophthalmol (2007) 0.79
The JNK binding domain of islet-brain 1 inhibits IL-1 induced JNK activity and apoptosis but not the transcription of key proapoptotic or protective genes in insulin-secreting cell lines. Cytokine (2003) 0.78
Registration of congenital anomalies in Switzerland by EUROCAT. Schweiz Med Wochenschr (2000) 0.78
Alterations of ocular motility in cerebellar pathology. An electro-oculographic study. Arch Neurol (1979) 0.78
[The blinking reflex in primary facial hemispasm: electromyographic considerations]. Electromyogr Clin Neurophysiol (1972) 0.78
Maternal and developmental toxicity of chronic aluminum exposure in mice. Fundam Appl Toxicol (1987) 0.78
The 5' repeat elements of the mouse Xist gene inhibit the transcription of X-linked genes. Gene Expr (2000) 0.78
Use of denaturing HPLC and automated sequencing to screen the VMD2 gene for mutations associated with Best's vitelliform macular dystrophy. Ophthalmic Genet (2002) 0.78
Electromagnetic interference of bone-anchored hearing aids by cellular phones. Acta Otolaryngol (2000) 0.78
[Familial hyperekplexia: startle disease. Clinical, electrophysiological and genetic study of a family]. Rev Neurol (Paris) (1996) 0.77
The human TAX1 gene encoding the axon-associated cell adhesion molecule TAG-1/axonin-1: genomic structure and basic promoter. Genomics (1995) 0.77
Further delineation of the facial 13q14 deletion syndrome in 13 retinoblastoma patients. Ophthalmic Genet (2001) 0.77
A new case of Pfeiffer syndrome with mutation in FGFR2. Genet Couns (1997) 0.77
MYOC mutation frequency in primary open-angle glaucoma patients from Western Switzerland. Ophthalmic Genet (2001) 0.77
Saliva as an analytical tool to measure occupational exposure to toluene. Int Arch Occup Environ Health (2008) 0.77
Trichloroethylene in urine as biological exposure index. Ind Health (2001) 0.76
Frequency and impact of autosomal dominant polycystic kidney disease in the Seychelles (Indian Ocean). Nephrol Dial Transplant (1997) 0.76
Molecular and clinical characteristics in 32 families affected with familial adenomatous polyposis. Hum Mutat (2001) 0.76
Autotransfusion of shed mediastinal blood after cardiac operations. Ann Thorac Surg (1995) 0.76
Partial trisomy 20q in a newborn with dextrocardia. Genet Couns (2002) 0.76
Prognostic factors associated with loss of heterozygosity at the RB1 locus in retinoblastoma. Ophthalmic Genet (1997) 0.76
[Monitoring air dispersed concentrations of aldehydes during the use of ortho-phthalaldehyde and glutaraldehyde for high disinfection of endoscopes]. G Ital Med Lav Ergon (2003) 0.76
ERK1/2 pathway is activated in degenerated Rpe65-deficient mice. Exp Eye Res (2013) 0.76
[Chromosome 5q31 linked corneal dystrophies: outline for a new classification]. Klin Monbl Augenheilkd (2001) 0.75
[Diabetes and genetics: significance of intracellular signaling pathways]. Rev Med Suisse Romande (2000) 0.75
[Experimental study on the kinetics of plasmatic depuration of indocyanine green, a suitable substance for the determination of hepato-biliary parenchymal clearance]. Rass Clin Ter (1966) 0.75